Φορτώνει......
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
INTRODUCTION: Upadacitinib is a Janus kinase inhibitor with demonstrated efficacy in patients with rheumatoid arthritis (RA). OBJECTIVE: The aim of this study was to assess the long-term safety of upadacitinib in patients with active RA from Japan compared with global clinical trial populations. MET...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Drug Saf |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer International Publishing
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184701/ https://ncbi.nlm.nih.gov/pubmed/34041702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-021-01067-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|